"Patients treated with hemodialysis (HD) have been reported to have decreased levels of omega-3 polyunsaturated fatty acids (PUFAs) in plasma and cells. The aim of this study was to investigate the effect of omega-3 PUFAs administered intravenously during HD, as well as the effect of HD treatment, on the fatty acid composition of plasma free fatty acids (FFAs), plasma phospholipids, and platelet phospholipids," scientists in Aalborg, Denmark report (see also Renal Disease).
"Forty-four HD patients were randomized to groups receiving either a single dose of a lipid emulsion containing 4.1 g of omega-3 PUFAs or placebo (saline) administered intravenously during HD. Blood was …
Комментариев нет:
Отправить комментарий